MPS Limited, through its wholly-owned subsidiary MPS North America LLC, has announced its agreement to acquire a 100% stake in Unbound Medicine, Inc., a United States-based healthcare technology and medical information company. This acquisition marks MPS Limited's strategic entry into the healthcare and medical information technology segment, a high-growth area adjacent to its core strengths in digital publishing and learning platforms. Unbound Medicine, founded in 1999, is a provider of digital medical reference, clinical decision-support, and healthcare learning solutions. It operates proprietary mobile-first and web-based platforms delivering evidence-based medical content to healthcare professionals, academic institutions, and professional associations through a subscription-led institutional business model. The company has a significant presence across the United States and Canada. This transaction is aligned with MPS Limited's long-term growth strategy of building platform-led, recurring-revenue businesses. It is expected to complement MPS' existing capabilities, drive revenue diversification, create cross-selling opportunities, foster AI-driven innovation, and deepen its presence in the North American market. Both companies anticipate accelerated global mission delivery and enhanced value creation through this strategic move.
